Screener
Actinium Pharmaceuticals ATNM Q4 2025 Annual earnings
Reported March 30, 2026
EPS-$0.19Miss by $0.00
Revenue estimate$600.0K
EPS estimate-$0.19
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$1.2M
EPS estimate-$0.25
Versus estimates
Diluted EPS
FAQ
- When did Actinium Pharmaceuticals report Q4 2025 earnings?
- Actinium Pharmaceuticals (ATNM) reported Q4 2025 earnings on March 30, 2026.
- What were Actinium Pharmaceuticals's Q4 2025 revenue and EPS?
- Actinium Pharmaceuticals reported eps of $-0.19 for Q4 2025.
- Did Actinium Pharmaceuticals beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.19 by $0.00.
- How did Actinium Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 9.5% from $-0.21.
- Where can I find Actinium Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-26-036504) directly on SEC EDGAR. The filing index links above go to sec.gov.
